E-LIB Suche - Ergebnisse für: Brigandi, Richard A.

1

Intradermal substance P as a challenge agent in healthy ind..:

ten Voorde, Wouter ; Akinseye, Chika ; Abdisalaam, Ismahaan...
Clinical and Translational Science. 16 (2023) 10 - p. 1856-1865 , 2023

Link: https://doi.org/10.1111/..

2

A Phase 1 Randomized, Placebo‐Controlled Trial With a Topic..:

Brigandi, Richard A. ; Zhu, John ; Murnane, Amy A...
Clinical Pharmacology in Drug Development. 8 (2019) 3 - p. 270-280 , 2019

Link: https://doi.org/10.1002/..

3

A population analysis of the DGAT1 inhibitor GSK3008356 and..:

Okour, Malek ; Brigandi, Richard A. ; Tenero, David
Fundamental & Clinical Pharmacology. 33 (2019) 5 - p. 567-580 , 2019

Link: https://doi.org/10.1111/..

4

First‐in‐Human Pharmacokinetics and Safety Study of GSK3008..:

Okour, Malek ; Gress, Angela ; Zhu, Xinyi...
Clinical Pharmacology in Drug Development. 8 (2019) 8 - p. 1088-1099 , 2019

Link: https://doi.org/10.1002/..

5

A Novel Hypoxia-Inducible Factor−Prolyl Hydroxylase Inhibit..:

Brigandi, Richard A. ; Johnson, Brendan ; Oei, Coreen...
American Journal of Kidney Diseases. 67 (2016) 6 - p. 861-871 , 2016

Link: https://doi.org/10.1053/..

6

Intravenous pharmacokinetics, local tolerability, and hemol..:

Brigandi, Richard A. ; Russ, Steven F. ; Petit, Chantal...
Clinical Pharmacology in Drug Development. 4 (2014) 2 - p. 130-136 , 2014

Link: https://doi.org/10.1002/..

7

Farglitazar Lacks Antifibrotic Activity in Patients With Ch..:

McHutchison, John ; Goodman, Zachary ; Patel, Keyur...
Gastroenterology. 138 (2010) 4 - p. 1365-1373.e2 , 2010

Link: https://doi.org/10.1053/..

8

Synthesis, Antimalarial Activity, and Preclinical Pharmacol..:

O'Neill, Paul M. ; Shone, Alison E. ; Stanford, Deborah...
Journal of Medicinal Chemistry. 52 (2009) 7 - p. 1828-1844 , 2009

Link: https://doi.org/10.1021/..

9

Candidate Selection and Preclinical Evaluation of N-tert-Bu..:

O'Neill, Paul M. ; Park, B. Kevin ; Shone, Alison E....
Journal of Medicinal Chemistry. 52 (2009) 5 - p. 1408-1415 , 2009

Link: https://doi.org/10.1021/..

10

Strongyloides stercoralis:Eosinophil-Dependent Immune-Media..:

Rotman, Harris L. ; Yutanawiboonchai, Wiboonchai ; Brigandi, Richard A....
Experimental Parasitology. 82 (1996) 3 - p. 267-278 , 1996

Link: https://doi.org/10.1006/..

11

Strongyloides stercoralis:Role of Antibody and Complement i..:

Brigandi, Richard A. ; Rotman, Harris L. ; Yutanawiboonchai, Wiboonchai...
Experimental Parasitology. 82 (1996) 3 - p. 279-289 , 1996

Link: https://doi.org/10.1006/..

12

Strongyloides stercoralis Host-Adapted Third-Stage Larvae A..:

Richard A. Brigandi ; Harris L. Rotman ; Ofra Leon...
The Journal of Parasitology. 84 (1998) 2 - p. 440-445 , 1998

Link: https://www.jstor.org/st..

13

Intradermal substance P as a challenge agent in healthy ind..:

ten Voorde, Wouter ; Akinseye, Chika ; Abdisalaam, Ismahaan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582677/. , 2023

Link: http://www.ncbi.nlm.nih...

14

A Phase 1 Randomized, Placebo‐Controlled Trial With a Topic..:

Brigandi, Richard A ; Zhu, John ; Murnane, Amy A..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590436/. , 2019

Link: http://www.ncbi.nlm.nih...

15

A novel hypoxia-inducible factor-prolyl hydroxylase inhibit..:

Brigandi, Richard A ; Johnson, Brendan ; Oei, Coreen...
Brigandi , R A , Johnson , B , Oei , C , Westerman , M E , Olbina , G , de Zoysa , J R , Roger , S D , Sahay , M , Cross , N B , McMahon , L , Guptha , V , Smolyarchuk , E A , Singh , N , Russ , S F , Kumar , S & PHI112844 Investigators 2016 , ' A novel hypoxia-inducible factor-prolyl hydroxylase inhibitor (GSK1278863) for anemia in CKD : A 28-day, phase 2A randomized trial ' , American Journal of Kidney Diseases , vol. 67 , no. 6 , pp. 861-871 . https://doi.org/10.1053/j.ajkd.2015.11.021. , 2016

Link: https://research.monash...